Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Jounce Therapeutics, Inc. (JNCE)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
4 Apr 2023
MURRAY RICHARD /CA/
Director
Jounce Therapeutics, Inc.
(JNCE)
188,779
-17%
39,228
$1.85
$72,571.81
SELL
9 Jan 2023
Drapkin Kimberlee C
CFO and Treasurer, Officer
Jounce Therapeutics, Inc.
(JNCE)
66,018
-17%
14,096
$1.11
$15,661.22
SELL
9 Jan 2023
Cole Hugh M
Chief Operating Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
110,082
-13%
16,634
$1.11
$18,481.04
SELL
9 Jan 2023
Trehu Elizabeth
Chief Medical Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
103,417
-8%
9,285
$1.11
$10,316.02
SELL
9 Jan 2023
MURRAY RICHARD /CA/
CEO and President, Director, Officer
Jounce Therapeutics, Inc.
(JNCE)
228,007
-16%
45,070
$1.11
$50,074.58
SELL
7 Jan 2022
Drapkin Kimberlee C
CFO and Treasurer, Officer
Jounce Therapeutics, Inc.
(JNCE)
52,614
-19%
12,817
$6.88
$88,219.80
SELL
7 Jan 2022
Trehu Elizabeth
Chief Medical Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
85,202
-8%
8,383
$6.88
$57,700.20
SELL
7 Jan 2022
Cole Hugh M
Chief Business Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
64,216
-13%
9,673
$6.88
$66,579.65
SELL
7 Jan 2022
MURRAY RICHARD /CA/
CEO and President, Director, Officer
Jounce Therapeutics, Inc.
(JNCE)
185,577
-16%
37,294
$6.88
$256,695.61
SELL
12 Nov 2021
Third Rock Ventures III, L.P.
10% Owner
Jounce Therapeutics, Inc.
(JNCE)
1,148,780
-62%
1,900,000
$8.38
$15,922,000.00
SELL
25 May 2021
Third Rock Ventures II, L.P.
10% Owner
Jounce Therapeutics, Inc.
(JNCE)
5,947,829
-8%
552,520
$8.00
$4,420,160.00
SELL
15 Apr 2021
Higgons John Duncan
Director
Jounce Therapeutics, Inc.
(JNCE)
9,713
-2%
200
$10.00
$2,000.00
SELL
29 Mar 2021
Trehu Elizabeth
Chief Medical Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
93,585
-12%
13,500
$10.09
$136,206.00
SELL
15 Mar 2021
Higgons John Duncan
Director
Jounce Therapeutics, Inc.
(JNCE)
9,913
-1%
200
$12.80
$2,560.00
SELL
1 Mar 2021
Third Rock Ventures II, L.P.
10% Owner
Jounce Therapeutics, Inc.
(JNCE)
7,750,349
-15%
1,450,000
$11.75
$17,037,500.00
SELL
16 Feb 2021
Higgons John Duncan
Director
Jounce Therapeutics, Inc.
(JNCE)
10,113
-1%
200
$11.78
$2,356.00
SELL
22 Jan 2021
Cole Hugh M
Chief Business Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
47,189
-27%
18,000
$11.95
$215,100.00
SELL
21 Jan 2021
MURRAY RICHARD /CA/
CEO and President, Director, Officer
Jounce Therapeutics, Inc.
(JNCE)
140,371
-19%
33,518
$12.06
$404,227.10
SELL
20 Jan 2021
Drapkin Kimberlee C
CFO and Treasurer, Officer
Jounce Therapeutics, Inc.
(JNCE)
43,181
-40%
30,000
$11.36
$340,786.03
SELL
20 Jan 2021
Trehu Elizabeth
Chief Medical Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
71,335
-8%
6,500
$12.01
$78,065.00
SELL
20 Jan 2021
Higgons John Duncan
Director
Jounce Therapeutics, Inc.
(JNCE)
10,313
-14%
1,700
$11.90
$20,222.00
SELL
15 Jan 2021
MURRAY RICHARD /CA/
CEO and President, Director, Officer
Jounce Therapeutics, Inc.
(JNCE)
140,371
-38%
86,482
$9.69
$838,243.25
SELL
7 Jan 2021
Drapkin Kimberlee C
CFO and Treasurer, Officer
Jounce Therapeutics, Inc.
(JNCE)
55,881
-9%
5,827
$6.89
$40,141.72
SELL
7 Jan 2021
Trehu Elizabeth
Chief Medical Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
71,335
-6%
5,298
$6.89
$36,497.52
SELL
7 Jan 2021
Cole Hugh M
Chief Business Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
55,189
-10%
6,219
$6.89
$42,842.04
SELL
7 Jan 2021
MURRAY RICHARD /CA/
CEO and President, Director, Officer
Jounce Therapeutics, Inc.
(JNCE)
140,371
-13%
21,999
$6.89
$151,549.10
SELL
19 Nov 2020
Third Rock Ventures II, L.P.
10% Owner
Jounce Therapeutics, Inc.
(JNCE)
9,200,349
-0%
15,000
$7.01
$105,075.00
SELL
17 Nov 2020
Third Rock Ventures II, L.P.
10% Owner
Jounce Therapeutics, Inc.
(JNCE)
9,215,349
-0%
15,000
$7.25
$108,772.50
SELL
15 Sep 2020
Duncan Barbara Gayle
Director
Jounce Therapeutics, Inc.
(JNCE)
5,000
-66%
10,000
$10.00
$100,000.00
SELL
1 Sep 2020
Drapkin Kimberlee C
CFO and Treasurer, Officer
Jounce Therapeutics, Inc.
(JNCE)
61,708
-10%
7,200
$8.06
$58,032.00
SELL
14 Aug 2020
Drapkin Kimberlee C
CFO and Treasurer, Officer
Jounce Therapeutics, Inc.
(JNCE)
68,908
-3%
2,182
$4.71
$10,276.44
SELL
14 Aug 2020
Trehu Elizabeth
Chief Medical Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
77,377
-2%
2,182
$4.71
$10,276.44
SELL
14 Aug 2020
Cole Hugh M
Chief Business Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
61,408
-3%
2,182
$4.71
$10,276.44
SELL
7 Jan 2020
Drapkin Kimberlee C
CFO and Treasurer, Officer
Jounce Therapeutics, Inc.
(JNCE)
44,390
-5%
2,624
$7.78
$20,414.72
SELL
7 Jan 2020
Trehu Elizabeth
Chief Medical Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
56,565
-4%
2,624
$7.78
$20,414.72
SELL
7 Jan 2020
Cole Hugh M
Chief Business Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
33,590
-7%
2,624
$7.78
$20,414.72
SELL
7 Jan 2020
MURRAY RICHARD /CA/
CEO and President, Director, Officer
Jounce Therapeutics, Inc.
(JNCE)
87,360
-7%
7,150
$7.78
$55,627.00
SELL
6 Jan 2020
Higgons John Duncan
Director
Jounce Therapeutics, Inc.
(JNCE)
12,013
-11%
1,500
$8.11
$12,165.00
SELL
23 Dec 2019
MURRAY RICHARD /CA/
CEO and President, Director, Officer
Jounce Therapeutics, Inc.
(JNCE)
94,510
-29%
40,000
$8.37
$334,800.00
SELL
14 Aug 2019
Drapkin Kimberlee C
CFO and Treasurer, Officer
Jounce Therapeutics, Inc.
(JNCE)
47,014
-4%
2,336
$3.99
$9,329.56
SELL
14 Aug 2019
Trehu Elizabeth
Chief Medical Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
59,189
-3%
2,336
$3.99
$9,329.56
SELL
14 Aug 2019
Cole Hugh M
Chief Business Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
36,214
-6%
2,336
$3.99
$9,329.56
BUY
15 Jun 2018
Cole Hugh M
Chief Business Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
1,900
+100%
1,900
$7.84
$14,896.00
SELL
15 Mar 2018
Duncan Barbara Gayle
Director
Jounce Therapeutics, Inc.
(JNCE)
0
-100%
2,000
$28.11
$56,220.00
SELL
8 Mar 2018
Drapkin Kimberlee C
CFO and Treasurer, Officer
Jounce Therapeutics, Inc.
(JNCE)
0
-100%
5,267
$25.01
$131,727.67
SELL
8 Mar 2018
Trehu Elizabeth
Chief Medical Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
0
-100%
4,545
$25.06
$113,897.70
SELL
8 Mar 2018
MURRAY RICHARD /CA/
CEO and President, Director, Officer
Jounce Therapeutics, Inc.
(JNCE)
0
-100%
16,334
$25.10
$409,983.40
SELL
5 Mar 2018
Drapkin Kimberlee C
CFO and Treasurer, Officer
Jounce Therapeutics, Inc.
(JNCE)
2,775
-65%
5,267
$21.42
$112,802.69
SELL
5 Mar 2018
Trehu Elizabeth
Chief Medical Officer, Officer
Jounce Therapeutics, Inc.
(JNCE)
1,366
-76%
4,545
$21.50
$97,724.22
SELL
5 Mar 2018
MURRAY RICHARD /CA/
CEO and President, Director, Officer
Jounce Therapeutics, Inc.
(JNCE)
4,234
-79%
16,334
$21.43
$350,043.03
SELL
26 Jan 2018
Duncan Barbara Gayle
Director
Jounce Therapeutics, Inc.
(JNCE)
0
-100%
4,000
$25.00
$100,000.00
BUY
1 Feb 2017
Celgene Switzerland LLC
10% Owner
Jounce Therapeutics, Inc.
(JNCE)
3,456,463
+22%
625,000
$16.00
$10,000,000.00
BUY
1 Feb 2017
KARSEN PERRY A
Director
Jounce Therapeutics, Inc.
(JNCE)
5,000
+100%
5,000
$16.00
$80,000.00
BUY
1 Feb 2017
Higgons John Duncan
Director
Jounce Therapeutics, Inc.
(JNCE)
27,025
+32%
6,700
$16.00
$107,200.00
Home